Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

1.

Drug Class Review: Topical Calcineurin Inhibitors: Final Report [Internet].

Lee NJ, McDonagh M, Chan B, Peterson K, Thakurta S.

Portland (OR): Oregon Health & Science University; 2008 Oct.

PMID:
20496106
[PubMed]
Books & Documents
2.

The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy.

Ring J, Möhrenschlager M, Henkel V.

Drug Saf. 2008;31(3):185-98. Review.

PMID:
18302444
[PubMed - indexed for MEDLINE]
3.

Therapy of atopic eczema.

Werfel T, Claes C, Kulp W, Greiner W, von der Schulenburg JM.

GMS Health Technol Assess. 2006 Oct 6;2:Doc19.

PMID:
21289970
[PubMed]
Free PMC Article
4.

Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.

Frankel HC, Qureshi AA.

Am J Clin Dermatol. 2012 Apr 1;13(2):113-23. doi: 10.2165/11597780-000000000-00000. Review.

PMID:
22263704
[PubMed - indexed for MEDLINE]
5.

Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.

Munzenberger PJ, Montejo JM.

Pharmacotherapy. 2007 Jul;27(7):1020-8. Review.

PMID:
17594208
[PubMed - indexed for MEDLINE]
6.

Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies.

Thaçi D, Salgo R.

Clin Dermatol. 2010 Jan-Feb;28(1):52-6. doi: 10.1016/j.clindermatol.2009.04.001. Review.

PMID:
20082951
[PubMed - indexed for MEDLINE]
7.

Safety of topical calcineurin inhibitors in atopic dermatitis: evaluation of the evidence.

Spergel JM, Leung DY.

Curr Allergy Asthma Rep. 2006 Jul;6(4):270-4. Review.

PMID:
16822378
[PubMed - indexed for MEDLINE]
8.

[Current aspects of the therapy with topical calcineurin inhibitors].

Enderlein E, Meller S, Rieker J, Ruzicka T, Homey B.

Hautarzt. 2005 Oct;56(10):937-41. German.

PMID:
16142499
[PubMed - indexed for MEDLINE]
9.

Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.

Breuer K, Werfel T, Kapp A.

Am J Clin Dermatol. 2005;6(2):65-77. Review.

PMID:
15799678
[PubMed - indexed for MEDLINE]
10.

Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis.

Abramovits W, Hung P, Tong KB.

Am J Clin Dermatol. 2006;7(4):213-22. Review.

PMID:
16901181
[PubMed - indexed for MEDLINE]
11.

Black box warning for topical calcineurin inhibitors and the death of common sense.

Fleischer AB Jr.

Dermatol Online J. 2006 Oct 31;12(6):2.

PMID:
17083882
[PubMed - indexed for MEDLINE]
12.

Atopic dermatitis: an overview.

Berke R, Singh A, Guralnick M.

Am Fam Physician. 2012 Jul 1;86(1):35-42. Review.

PMID:
22962911
[PubMed - indexed for MEDLINE]
Free Article
13.

Topical calcineurin inhibitors in pediatric atopic dermatitis: a critical analysis of current issues.

Orlow SJ.

Paediatr Drugs. 2007;9(5):289-99. Review.

PMID:
17927301
[PubMed - indexed for MEDLINE]
14.

Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.

Green C, Colquitt JL, Kirby J, Davidson P, Payne E.

Health Technol Assess. 2004 Nov;8(47):iii,iv, 1-120. Review.

PMID:
15527669
[PubMed - indexed for MEDLINE]
Free Article
15.

Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns.

Horii KA, Simon SD, Liu DY, Sharma V.

Pediatrics. 2007 Sep;120(3):e527-34.

PMID:
17766497
[PubMed - indexed for MEDLINE]
Free Article
16.

Cancer concerns with topical immunomodulators in atopic dermatitis: overview of data and recommendations to clinicians.

Patel TS, Greer SC, Skinner RB Jr.

Am J Clin Dermatol. 2007;8(4):189-94. Review.

PMID:
17645374
[PubMed - indexed for MEDLINE]
17.

Topical calcineurin inhibitors labeling: putting the "box" in perspective.

Stern RS.

Arch Dermatol. 2006 Sep;142(9):1233-5. No abstract available.

PMID:
16983018
[PubMed - indexed for MEDLINE]
18.

The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis.

Wollina U.

Am J Clin Dermatol. 2007;8(3):157-73. Review.

PMID:
17492844
[PubMed - indexed for MEDLINE]
19.

The black box warning for topical calcineurin inhibitors: looking outside the box.

Fonacier L, Charlesworth EN, Spergel JM, Leung DY.

Ann Allergy Asthma Immunol. 2006 Jul;97(1):117-20. Review. No abstract available.

PMID:
16892793
[PubMed - indexed for MEDLINE]
20.

Association between exposure to topical tacrolimus or pimecrolimus and cancers.

Hui RL, Lide W, Chan J, Schottinger J, Yoshinaga M, Millares M.

Ann Pharmacother. 2009 Dec;43(12):1956-63. doi: 10.1345/aph.1M278. Epub 2009 Nov 10.

PMID:
19903860
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk